CD70 and agammaglobulinemia: In our previous study, we have shown that the clinical and immunologic findings on the first two CD70-deficient individuals indicate a terminal B-cell developmental defect and a reduced T-cell effector function underlying their antibody deficiency, susceptibility to viral infection, autoimmunity, and lymphoid malignancy.